Aquaporin A/S (CPH: AQP)
Denmark
· Delayed Price · Currency is DKK 22.10
-0.10 (-0.45%)
Nov 20, 2024, 3:39 PM CET
Aquaporin Revenue
Aquaporin had revenue of 23.00M DKK in the quarter ending June 30, 2024, with 146.37% growth. This brings the company's revenue in the last twelve months to 68.50M, up 82.18% year-over-year. In the year 2023, Aquaporin had annual revenue of 59.53M with 94.84% growth.
Revenue (ttm)
68.50M
Revenue Growth
+82.18%
P/S Ratio
3.23
Revenue / Employee
867.08K
Employees
82
Market Cap
507.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 59.53M | 28.98M | 94.84% |
| Dec 31, 2022 | 30.55M | 21.63M | 242.46% |
| Dec 31, 2021 | 8.92M | 3.42M | 62.25% |
| Dec 31, 2020 | 5.50M | -579.00K | -9.53% |
| Dec 31, 2019 | 6.08M | -1.82M | -23.00% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ørsted A/S | 71.49B |
| Green Hydrogen Systems A/S | 59.87M |
| Novo Nordisk A/S | 270.58B |
| DSV A/S | 160.12B |
| Nordea Bank Abp | 88.42B |
| Coloplast A/S | 27.03B |
| Novozymes A/S | 22.71B |
| A.P. Møller - Mærsk A/S | 351.89B |